Previous Close | 110.27 |
Open | 110.84 |
Bid | 111.72 x 800 |
Ask | 111.75 x 900 |
Day's Range | 110.71 - 112.13 |
52 Week Range | 101.24 - 142.60 |
Volume | |
Avg. Volume | 5,054,212 |
Market Cap | 194.946B |
Beta (5Y Monthly) | 0.70 |
PE Ratio (TTM) | 23.24 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 1.88 (1.74%) |
Ex-Dividend Date | Jul 14, 2022 |
1y Target Est | N/A |
BALTIMORE, August 1, 2022 /3BL Media/ - To address the urgent cybersecurity talent needs in the U.S., Advancing Minorities' Interest in Engineering (AMIE) announced a new collaboration to support c...
Parkinson's Foundation survey says vast majority find greater access to remote care via NeuroSphere Virtual Clinic.
Abbott (NYSE: ABT) announces the Health Canada licencing†of NeuroSphere™ Virtual Clinic, a remote programming technology that is the first of its kind in Canada and is compatible with Abbott's suite of neuromodulation technologies. NeuroSphere Virtual Clinic has the potential to increase access to optimal treatment for patients living with chronic pain, Parkinson's disease, or essential tremors who might otherwise have difficulty receiving care from their healthcare provider due to location or